The First Successful Attempt to Study Alzheimer’s Disease Using Lab-Derived Neurons
https://pixabay.com/en/nerve-cell-neuron-brain-neurons-2213009/

The First Successful Attempt to Study Alzheimer’s Disease Using Lab-Derived Neurons

Researchers at Washington University’s medical school have used a new technique to study brain neurons in a lab setting, allowing them to bypass the need to rely on a brain…

Continue Reading The First Successful Attempt to Study Alzheimer’s Disease Using Lab-Derived Neurons
Rare Community Profiles: How Two Participants Found Connection and Support at the Marfan Foundation’s 2024 Global Virtual Conference
source: pixabay.com

Rare Community Profiles: How Two Participants Found Connection and Support at the Marfan Foundation’s 2024 Global Virtual Conference

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: How Two Participants Found Connection and Support at the Marfan Foundation’s 2024 Global Virtual Conference
Rare Community Profiles: He’s Only “1 of 20,” But Jonathan Cappiello’s Impact Extends Much Further
source: pixabay.com

Rare Community Profiles: He’s Only “1 of 20,” But Jonathan Cappiello’s Impact Extends Much Further

Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more. Jonathan…

Continue Reading Rare Community Profiles: He’s Only “1 of 20,” But Jonathan Cappiello’s Impact Extends Much Further
August is Gastroparesis Awareness Month!
source: shutterstock.com

August is Gastroparesis Awareness Month!

First established by the International Foundation for Gastrointestinal Disorders (IFFGD) in 2016, Gastroparesis Awareness Month is designed to increase awareness of gastroparesis and how it affects the people who have…

Continue Reading August is Gastroparesis Awareness Month!
A Genetic Analysis of Bacteria Strains Causing Lyme Disease Could Transform Treatment
JerzyGorecki / Pixabay

A Genetic Analysis of Bacteria Strains Causing Lyme Disease Could Transform Treatment

After years of research an international team of scientists has unraveled the genetic makeup of 47 strains of known and potential Lyme disease-causing bacteria. The work paves the way toward…

Continue Reading A Genetic Analysis of Bacteria Strains Causing Lyme Disease Could Transform Treatment
Why Dr. Fiorentino Believes in a Promising Treatment Future for Dermatomyositis
https://unsplash.com/photos/tWTFjznQlBA

Why Dr. Fiorentino Believes in a Promising Treatment Future for Dermatomyositis

In some cases, dermatomyositis can be difficult to treat. A variety of treatment options are available, from corticosteroids and immunosuppressants to antimalarials, colchicine, alendronate, and warfarin. But this rare condition…

Continue Reading Why Dr. Fiorentino Believes in a Promising Treatment Future for Dermatomyositis
New Podcast Episode: The Power of Resiliency, feat. Multiple Myeloma Patient Advocate Keisha Hickson
source: shutterstock.com

New Podcast Episode: The Power of Resiliency, feat. Multiple Myeloma Patient Advocate Keisha Hickson

Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is sitting down with professional speaker and…

Continue Reading New Podcast Episode: The Power of Resiliency, feat. Multiple Myeloma Patient Advocate Keisha Hickson
Positive Results from the Phase 3 Trial of ANX005 in Guillain-Barré Syndrome
source: shutterstock.com

Positive Results from the Phase 3 Trial of ANX005 in Guillain-Barré Syndrome

The long-awaited positive results of Annexon Inc.’s Phase 3 trial investigating ANX005 for Guillain-Barré syndrome (GBS) was presented at the PNS 2024 Annual Meeting. Several leading global GBS experts spoke…

Continue Reading Positive Results from the Phase 3 Trial of ANX005 in Guillain-Barré Syndrome
RNU4-2 Variants Cause Up to 0.4% of Neurodevelopmental Disorders
source: shutterstock.com

RNU4-2 Variants Cause Up to 0.4% of Neurodevelopmental Disorders

In unedited, early-access research published in Nature, a team of researchers explain that an estimated 60% of people with neurodevelopmental disorders remain undiagnosed, despite comprehensive genetic testing options. In many cases, this is…

Continue Reading RNU4-2 Variants Cause Up to 0.4% of Neurodevelopmental Disorders